Clinical Implications These interactions highlight the critical role of interdisciplinary collaboration between pharmacists, nutritionists, and healthcare providers
Custer said overweight and obese patients with Type 2 diabetes are typically more resistant to weight loss than those without the condition
This allows for precise administration, from initial low-dose induction to full maintenance dosing , supporting controlled R&D studies and investigational protocols
Cristy Gallagher, a research project director focused on obesity at the Milken Institute School of Public Health at George Washington University, recommends that anyone interested in Wegovy or Wegovy HD talk with their healthcare provider first to determine whether a GLP-1 medication is appropriate for them
Sample size calculation The sample size calculation was based on the assumptions of a mean difference in the primary endpoint CDR-SB score of 0.44 points (relating to a 20% difference between semaglutide and placebo when assuming a mean increase in the placebo arm of 2.2 points), standard deviation of 2.6 points, and one-sided significance level of 0.025
Buse, Etta D